Remotely powered implantable electrodes and related systems and methods for treating sleep apnea

JP2023548970A5Inactive Publication Date: 2024-11-13INVICTA MEDICAL
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
JP2023551951
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2020-11-04
Filing Date
2021-11-03
Publication Date
2024-11-13
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

Existing treatments for obstructive sleep apnea, such as surgery and continuous positive airway pressure devices, are invasive, uncomfortable, and have low compliance rates, while electrical stimulation techniques are not sufficiently effective.

Method used

A minimally invasive system comprising wearable and implantable devices that use RF signals to stimulate nerves in the oral cavity, specifically the hypoglossal nerve, to prevent tongue collapse during sleep, including a power storage device, power transmission antenna, electrode receiver antenna, and signal generator to deliver targeted electrical signals.

Benefits of technology

The system effectively maintains upper airway patency by moving the tongue forward, improving sleep quality and reducing obstructive sleep apnea symptoms with minimal discomfort and invasiveness.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

Disclosed herein are implantable electrodes with wearable power delivery devices and related systems and methods for treating sleep apnea. An exemplary system includes a non-implantable signal generator wearable by the patient, the non-implantable signal generator having an antenna that directs a mid-field RF signal to the implantable electrode. The implantable electrode then directs a low-frequency signal to a neural target, such as the patient's hypoglossal nerve. An exemplary signal generator may be in the form of a mouthpiece, a collar or other wearable device, and / or a skin-attached patch.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical Field]

[0001] The present technology relates generally to implantable electrodes wirelessly coupled to remotely powered (power delivery) devices for treating sleep apnea, and related systems and methods. Exemplary power delivery devices include devices worn in the form of mouthpieces, collars or other neck garments, and / or adhesive skin-attached devices.

[0002] CROSS-REFERENCE TO RELATED APPLICATIONS This application claims priority to U.S. Provisional Patent Application No. 63 / 109,809, filed November 4, 2020, which is incorporated by reference herein. To the extent that the application and / or any other document conflicts with this disclosure, this disclosure will control. [Background technology]

[0003] Obstructive sleep apnea (OSA) is a condition in which a patient's upper airway repeatedly becomes blocked (either partially or completely) during sleep, causing awakenings. The repeated blockages of the upper airway can cause sleep fragmentation, which can result in poor sleep, daytime fatigue, and / or lethargy. In more severe cases of OSA, patients may be at increased risk for stroke, cardiac arrhythmia, hypertension, and / or other disorders.

[0004] OSA is characterized by a tendency for the soft tissues of the upper airway to collapse or collapse during sleep, thereby obstructing the upper airway. OSA is typically caused by collapse of the soft palate, oropharynx, tongue, epiglottis, or a combination of these, into the patient's upper airway, which can interfere with normal breathing and / or arouse the sleep state. Summary of the Invention [Problem to be solved by the invention]

[0005] Several treatments are available for OSA, including surgery, continuous positive airway pressure (CPAP) machines, and electrical stimulation of the muscles associated with the upper airway that move the tongue (or other upper airway tissues). Surgical procedures include tracheostomy, surgery to remove part of the patient's tongue and / or soft palate, and other procedures that attempt to prevent the tongue from collapsing into the back of the pharynx. These surgical procedures are highly invasive. CPAP machines apply positive air pressure to the patient's nose and mouth in an attempt to keep the upper airway open. However, these machines can be uncomfortable, cumbersome, and have low compliance rates.

[0006] Some electrical stimulation techniques attempt to prevent the tongue from collapsing into the back of the pharynx by causing the tongue to protrude anteriorly (e.g., forward) and / or flatten during sleep. However, existing techniques for electrically stimulating nerves in a patient's oral cavity have drawbacks: they are too invasive and / or not effective enough. Thus, improved, minimally invasive treatments for OSA and other sleep disorders are needed. [Means for solving the problem]

[0007] According to one aspect of the present invention, there is provided a patient care system comprising: The wearable device includes: a power storage device; a transmitting antenna coupled to the power storage device and configured to emit RF signals in a frequency range from 300 MHz to 6 GHz; a first control circuit coupled between the power storage device and the power transmitting antenna; The implantable device includes: An electrode; a housing carrying an electrode; an anchor carried by the housing and positioned to secure the implantable device to tissue within the patient's oral cavity; an electrode receiver antenna configured to receive RF signals in the frequency range of 300 MHz to 6 GHz; a signal generator coupled to the electrode receiver antenna and to the electrode to direct a signal to the electrode at a frequency ranging from 10 Hz to 300 Hz; A patient treatment system is provided that includes a second circuitry coupled between the signal generator and the electrode for controlling delivery of the signal to the electrode.

[0008] According to another aspect of the present invention, there is provided a sleep apnea treatment system, comprising: an oral appliance configured to fit within the patient's oral cavity, the oral appliance comprising: a lower mouthpiece portion carrying a transmitting antenna configured to emit an RF signal at a first frequency; and an upper mouthpiece portion located opposite the lower mouthpiece portion, a power storage device operably coupled to the transmitting antenna; and carrying a first control circuit portion operably coupled to the power storage device and the transmitting antenna; A connector is provided to connect the lower mouthpiece portion and the upper mouthpiece portion, The implantable device includes: An electrode; an electrode receiver antenna configured to receive the RF signal emitted by the transmitting antenna; a signal generator coupled to the electrode receiver antenna and the electrode and capable of directing a stimulation signal to the electrode at a second frequency; and A sleep apnea treatment system is provided that includes a second circuit portion coupled between the signal generator and the electrode for controlling delivery of a stimulation signal to the electrode.

[0009] According to yet another aspect of the present invention, there is provided a method of directing an electrical signal to an individual, comprising the steps of: programming the wearable device to transmit a first electrical signal via a transmitting antenna of the wearable device positioned in wireless communication with a receiver antenna of the implantable device, at least a portion of the first electrical signal having a first frequency in a first frequency range of about 300 MHz to about 6 GHz; Program the implantable device's pulse generator receiving a first electrical signal via the electrode receiver antenna; and A method is provided, comprising transmitting a second electrical signal via at least one electrode of an implantable device positioned in electrical communication with a target nerve of the individual, wherein at least a portion of the second electrical signal has a second frequency in a second frequency range up to 100 kHz.

[0010] According to yet another aspect of the present invention, there is provided a method of treating a patient, comprising the steps of: percutaneously implanting an implantable device near the patient's medial branch of the hypoglossal nerve such that an electrode carried by the implantable device is positioned in electrical communication with the patient's medial branch of the hypoglossal nerve; transmitting a first signal from a transmitting antenna of the wearable device to a receiver antenna of the implantable device; converting the first signal into a second signal by a signal generator of the implantable device; and applying a second signal via an electrode to the patient's medial branch of the hypoglossal nerve.

[0011] Representative embodiments of the present technology are shown by way of example, and not by way of limitation, in the figures, in which like reference characters generally indicate corresponding parts throughout the figures. [Brief explanation of the drawings]

[0012] [Figure 1] FIG. 1 is a side cross-sectional view showing the upper airway of a patient. [Figure 2A]FIG. 1 is a view from below of a patient's skull showing the hypoglossal nerve and representative electrode placement locations in accordance with an embodiment of the present invention. [Figure 2B] FIG. 10 is a lateral view of a patient's skull illustrating another exemplary signal transmission target in accordance with an embodiment of the present technology. [Figure 3A] FIG. 1 is a block diagram illustrating components of a system for treating sleep disorders in accordance with an embodiment of the present technology. [Figure 3B] 1 is a partial schematic cross-sectional side view of a patient's upper airway and components of a system for treating sleep disorders in accordance with an embodiment of the present technology; [Figure 4] 1 is a partial schematic diagram of a signal transmission device configured in accordance with an embodiment of the present technology; [Figure 5A] 1 is a partial schematic diagram of a signal generator having an upper mouthpiece portion, a lower mouthpiece portion, and circuitry and power supplies positioned at the interior surface of the lower mouthpiece portion. [Figure 5B] 1 is a partial schematic diagram of a signal generator having an upper mouthpiece portion, a lower mouthpiece portion, and circuitry and power supplies positioned at the interior surface of the upper mouthpiece portion. [Figure 5C] 1 is a partial schematic diagram of a signal generator having an upper mouthpiece portion, a lower mouthpiece portion, and circuitry and power supplies positioned at the exterior surfaces of the upper and / or lower mouthpiece portions. [Figure 6] 1 is a partial schematic isometric view of a signal transmission device having an upper mouthpiece portion with a roof portion carrying circuitry, a power source, one or more sensors, and / or a data receiver antenna in accordance with an exemplary embodiment of the present technology; [Figure 7] 1 is a partial schematic diagram of a number of device configurations in which individual electrodes are controlled by a control circuit in accordance with an embodiment of the present invention. [Figure 8A] 1A-1C illustrate representative examples of waveforms with waveform parameters selected in accordance with embodiments of the present technology. [Figure 8B] 1A-1C illustrate representative examples of waveforms having active and rest periods in accordance with embodiments of the present technology. DETAILED DESCRIPTION OF THE INVENTION

[0013] For ease of reading, the technology is described under the following headings: · Heading 1 :"introduction" · Heading 2 : "Representative stimulus targets" (focus on Figures 1 to 2B) · Heading 3 : "Representative Instruments and Methods" (Focus on Figures 3A to 7) · Heading 4 : "Representative Waveforms" (focusing on Figures 8A and 8B)

[0014] Although embodiments of the present technology are described under selected headings above, other embodiments of the present technology may include components described under multiple headings. Thus, the fact that an embodiment may be described under a particular heading does not necessarily mean that the embodiment is limited to only the components described under that heading.

[0015] 1. Introduction Electrical stimulation for obstructive sleep apnea (OSA) typically involves passing electrical current that conditions nerves and / or muscles to induce tongue and / or other soft tissue movement. Thus, electrical stimulation can relieve upper airway obstruction and prevent the tongue or other soft tissue from collapsing or obstructing the airway. As used herein, the terms "conditioning" and "stimulation" are used interchangeably to refer to an effect on one or more motor functions, e.g., breathing-related motor functions, e.g., an effect on nerves that affect such motor functions.

[0016] Exemplary methods and devices for reducing the incidence and / or severity of respiratory disorders, such as OSA, are disclosed herein. According to exemplary embodiments, a minimally invasive signal-transmitting device is implanted near or adjacent to nerves innervating a patient's oral cavity, soft palate, oropharynx, and / or epiglottis. Exemplary nerves include the hypoglossal nerve, branches of the cervical fasciculus, and / or vagus nerve, which are located adjacent to and / or around the oral cavity or in the neck. The signal-transmitting device may be implanted in the patient via percutaneous injection. A non-implanted power source, including, for example, one or more mouthpiece components, collar components, chin strap components, pillow components, mattress overlay components, other suitable "wearable" components, and / or one or more adhesive skin-attached devices, may provide power wirelessly to the implanted signal-transmitting device. The signal-transmitting device emits precisely targeted electrical signals (e.g., pulses) that improve the patient's upper airway patency and / or improve tissue tone in the oral cavity to treat sleep apnea. The electrical current delivered by the signal delivery device can stimulate at least a portion of an efferent peripheral nerve, e.g., the patient's hypoglossal nerve and / or other nerves associated with the upper airway. By moving the tongue forward and / or preventing the tongue and / or soft tissue from collapsing onto the back of the patient's pharynx and / or onto the upper airway, the devices and related methods disclosed herein can improve a patient's sleep quality, for example, by moving potentially obstructive tissues in the upper airway / pharynx downward. Specifically, applying an electrical signal to the medial branch of the hypoglossal nerve can move the tongue forward (anteriorly), and applying an electrical signal to the cervical nerve trap can move the thyroid, larynx, trachea, and / or any of these tissues (e.g., cartilage) downward (inferiorly or caudally), such movement commonly referred to as caudal traction. The system may further include one or more feedback and / or diagnostic devices or functions that control the presence, timing, and / or manner in which electrical therapy is delivered to the patient.Thus, one or more sensors can detect patient characteristics (e.g., sleep state, wakefulness state, and / or respiratory characteristics) that can be used to measure treatment or therapy in real time or near real time, such that the system can deliver treatment to neural targets only when the patient is asleep and / or when the patient's respiratory performance (e.g., oxygen perfusion level) indicates that treatment is necessary or beneficial.

[0017] Many embodiments of the technology described below may take the form of computer-executable, machine-executable, or controller-executable instructions, including routines executed by a programmable computer or controller. Those skilled in the art will understand that the technology can be implemented in computer / controller systems other than those illustrated and described below. The technology can be embodied in special-purpose computers, controllers, or data processors that are specifically programmed, configured, or set up to execute one or more of the computer-executable instructions described below. Thus, as used generally herein, "computer" and "controller" refer to any suitable data processor, and these terms may include Internet applications and handheld devices (e.g., palmtop computers, wearable computers, tablets, cellular telephones, mobile phones, multiprocessor systems, processor-based consumer electronics, programmable consumer electronics, network computers, minicomputers, etc.). Information manipulated by these computers can be presented on any suitable display medium, including liquid crystal displays (LCDs).

[0018] The technology can also be practiced in distributed environments where tasks or modules are performed by remote processing devices that are linked together through a communications network. In a distributed computing environment, program modules or subroutines can be implemented in local and remote memory storage devices. Aspects of the technology described below can be stored or distributed on any suitable computer-readable medium, including one or more ASICs (e.g., with addressable memory), and can be electronically distributed over a network. Data structures and data transmission specific to aspects of the technology are also within the scope of embodiments of the technology.

[0019] 2. Representative Stimulation Targets Representative embodiments described herein include a signal delivery device having electrodes that may be positioned to deliver one or more electrical currents to one or more specific target locations, such as specific nerves and / or specific locations along the nerves. FIG. 1 illustrates the general anatomy of a patient's oral cavity, with subsequent figures illustrating specific target locations. Such locations include locations along the patient's hypoglossal nerve, branches of the cervical fasciculus, and / or vagus nerve, such as nerves that innervate muscles of the airway other than the tongue (e.g., palatal, oropharyngeal, and laryngeal muscles). Target locations may be identified relative to any of the following: intrinsic muscles, extrinsic muscles, associated nerve branches, and / or other physiological features, or any combination thereof. Such target locations and / or locations may also be located away from salivary glands (e.g., located inside the sublingual salivary glands) and / or other structures to avoid causing pain and / or other undesirable effects.

[0020] FIG. 1 illustrates a patient P in a coordinate system in which the x-axis indicates an anterior-posterior direction, the y-axis indicates a superior-inferior direction, and the z-axis indicates a medial-lateral direction. The patient P has a hard palate HP, which is located above the tongue T and forms the roof of the oral cavity (e.g., mouth). The hard palate HP has a bony support BS and thus does not normally deform during breathing. The soft palate SP, which is made of soft tissues, e.g., membranes, fibrous tissue, fatty tissue, and muscle tissue, extends posteriorly (e.g., posteriorly) from the hard palate HP toward the back of the pharynx PHR. More specifically, the anterior end AE of the soft palate SP is fixed to the posterior end of the hard palate HP, and the posterior end PE of the soft palate SP is free. Because the soft palate SP does not contain bone or hard cartilage, the soft palate SP can flex and collapse into the back of the pharynx PHR and / or flop back and forth (e.g., particularly during sleep).

[0021] The pharyngeal PHR, which transports air from the oral cavity (OC) and nasal cavity (NC) to the trachea (TR), is the portion of the throat located below (inferior to) the nasal cavity, behind (behind) the oral cavity (OC), and above (superior to) the esophagus (ES). The pharyngeal PHR is separated from the oral cavity (OC) by the palatoglossal arches (PGA), which extend downward on both sides toward the base of the tongue (T). For simplicity, the pharyngeal PHR includes the nasopharynx, oropharynx, and laryngopharynx, although not shown. The nasopharynx is located between the superior surface of the soft palate (SP) and the wall of the throat (i.e., above the oral cavity (OC)). The oropharynx is located behind the oral cavity (OC) and extends from the uvula (U) to the level of the hyoid bone (HB). The oropharynx opens anteriorly into the oral cavity (OC). The lateral walls of the oropharynx consist of the palatine tonsils and are located between the palatoglossal arches (PGA) and the palatopharyngeal arches. The anterior wall of the oropharynx consists of the base of the tongue (T) and the epiglottic vallecula. Because both food and air pass through the pharynx (PHR), a flap of connective tissue called the epiglottis (EP) covers the glottis (not shown for simplicity) when food is swallowed to prevent aspiration. The larynx is the part of the throat that connects to the esophagus (ES) and is located below the epiglottis (EP). Beneath the tongue (T) is the lower jaw (M) and the geniohyoid muscle (GH), which is one of the muscles that control the movement of the tongue (T).

[0022] FIG. 2A is a partial schematic isometric view of a patient's skull, viewed upward toward the mandible M. FIG. 2A also shows the hypoglossal nerve HGN, which innervates muscles controlling the patient's tongue T (FIG. 1). In an exemplary embodiment, one or more electrodes 131 are positioned along the hypoglossal nerve HGN, specifically at the medial branch of the HGN, within an electrode plane 132 defined by the medial branch. By precisely positioning the electrodes 131 within this plane 132 and adjacent to the hypoglossal nerve HGN, systems according to embodiments of the present technology can more effectively control a patient's airway patency without causing discomfort and / or other undesirable effects and / or in a manner that reduces the amount of power required to produce an effective therapeutic signal. As described elsewhere herein, other exemplary target nerves include the cervical fasciculus and vagus nerve. Further exemplary targets include the cranial nerves (e.g., glossopharyngeal nerve) and the palatoglossus muscle. FIG. 2B illustrates these targets. An exemplary system for achieving these and / or other results with a signal directed at the target is further described below with reference to FIGS. 3-8B.

[0023] 3. Representative instruments and methods 3A is a block diagram illustrating components of a system 100 for treating a sleep disorder in accordance with an embodiment of the present technology. System 100 may include a wearable device 101 (hereinafter sometimes referred to as a “wearable”), a charger 121, one or more implants or implantable devices (e.g., a first implantable device 120a, a second implantable device 120b, ... an nth implantable device 120n (collectively referred to as “implantable devices 120”), and a connected device or programmer 160. Generally, programmer 160 can transmit instructions to wearable device 101 to generate electrical signals (e.g., signal transmission or waveform parameters), which can in turn transmit instructions and power to implantable devices 120, which can generate and apply electrical signals to a patient via electrodes carried by implantable devices 120 according to the transmitted instructions. Many of the above-described aspects of system 100 are also described in more detail below with reference to FIG. 3B.

[0024] Programmer 160 may include a patient-operated programmer and / or a physician-operated programmer, which may be configured to control one or more characteristics of the electrical signal delivered to the patient. In an exemplary embodiment, programmer 160 may include a therapy adjustment module configured to select individual electrodes carried by implantable device 120 and adjust (e.g., increase or decrease) amplitude, frequency, pulse width, burst duration (whether the electrode is active or inactive), and / or any other suitable signal delivery parameters. Additionally, programmer 160 may synchronize information (e.g., diagnostic and / or feedback information) received from individual wearable devices 101 and / or implantable devices 120 and adjust one or more of the signal delivery parameters based at least in part on the synchronization information. Programmer 160 may transmit the signal delivery parameters directly to implantable device 120 and / or via wearable device 101. For example, programmer 160 may be connected to each implantable device 120 and / or wearable device 101 via a wired or wireless communication link, such as Wi-Fi, Bluetooth (BT), a cellular connection, and / or any other suitable communication link. In these and other embodiments, programmer 160 may be connected to a cloud 162 and / or other computer service, for example, to upload data received from sensors in wearable device 101 and / or to download information to wearable device 101 and / or implantable device 120. In these and other embodiments, programmer 160 may include a display and / or user interface. A user (e.g., a patient, a physician, and / or other suitable user) may interact with and / or otherwise control one or more aspects of programmer 160, for example, via the user interface, to manually adjust one or more signal transmission parameters, read data received from sensors in wearable device 101, and / or perform other tasks.

[0025] The wearable device 101 may include one or more sensors (e.g., a single sensor, an array of sensors, and / or other suitable sensor arrangements) configured to collect data related to the patient. The wearable device may further include a power source (e.g., a power storage device and / or battery), a power transmission component configured to transmit power and / or signal delivery parameters to the implantable device 120, and one or more algorithms configured to control one or more aspects of the operation of the wearable device 101. Each sensor may collect data related to the patient, such as the patient's sleep state and / or respiratory performance. The one or more algorithms may be configured to adjust at least one of the signal delivery parameters based, at least in part, on the data collected by the sensors. In an exemplary embodiment, the wearable device 101 may include an integrated sleep, respiratory diagnostic, and / or therapy modulation system configured to adjust or otherwise control one or more delivery parameters of the electrical signal delivered to the patient based on the collected sleep state and / or respiratory performance data, for example, via one or more algorithms.

[0026] In some embodiments, the wearable instrument 101 may further include a cover or housing, at least a portion of which may be removable to expose the interior or a portion of the wearable instrument 101. In this and other embodiments, the cover of the wearable instrument 101 may comprise a fabric or any other suitable material. Optionally, the wearable instrument 101 may have a reduced and / or simplified user interface configured to allow a user to interact with and / or otherwise control one or more of the components of the wearable instrument 101 (e.g., check the charge status of the power source, adjust one or more of the signal transmission parameters, etc.).

[0027] Charger 121 for wearable instrument 101 may be configured to provide power to a power source of wearable instrument 101. Charger 121 may include a wireless (e.g., inductive) charger, a wired charger (e.g., wall plug, charging cable, etc.), and / or any other suitable charger or charging device. Optionally, charger 121 may have an integrated controller and / or a connectivity device, for example, to control charging of wearable instrument 101 and / or to upload / download data to wearable instrument 101 while it is charging.

[0028] Each of the one or more implantable devices 120 may include an RFID tag (e.g., a unique RFID tag that can be used to identify and / or locate the associated implantable device 120a-120n), an electrode receiver antenna (e.g., an RF power antenna), a power rectifier (forward converter) / DC-DC converter, circuitry (e.g., one or more application specific integrated circuits (ASICs), state machines, etc.), a signal generator, and two or more electrodes, each individually selectable to deliver an electrical signal to the patient. The electrode receiver antenna may receive power from a power transmission component of the wearable device. The power rectifier / DC-DC converter may be operatively coupled to the electrode receiver antenna and may be configured to transmit the received power to the signal generator. Additionally, each of the implantable devices 120 may receive, via the electrode receiver antenna, information regarding one or more delivery parameters of an electrical signal to be generated by the signal generator and / or delivered to the patient via at least one of the electrodes of the implantable device 120. The circuitry may include machine-readable instructions associated with the operation of implantable device 120. For example, the circuitry may include instructions that, when executed, cause the signal generator to generate an electrical signal having signaling parameters received via the electrode receiver antenna. In these and other embodiments, the electrode receiver antenna may be used to transmit information associated with implantable device 120 to wearable device 101. For example, implantable device 120 may transmit information associated with one or more of the signaling parameters of an electrical signal applied to the patient to wearable device 101 via the electrode receiver antenna. In these and other embodiments, one or more implantable devices 120 may each have a hermetic package or housing configured to enable implantation of implantable device 120 within the patient's body.

[0029] FIG. 3B is a partial, schematic, isometric view of an exemplary embodiment of system 100 of FIG. 3A , shown in relation to a patient's anatomy, from a perspective similar to that described above with reference to FIG. 1 . In an exemplary embodiment, system 100 includes both implanted and external components. The implanted components may include one or more implantable devices 120. Each implantable device 120 may have a signal transmission device 130 positioned adjacent to a target nerve and / or muscle structure. The signal transmission device 130 may be secured in place by sutures and / or other devices, such as anchors. The signal transmission device 130 is operably coupled to the signal generator 110. In some embodiments, all signal generation functions are performed by the implantable device 120, while in other embodiments, some signal generation functions may be performed by external components. The signal generation and transmission functions may be performed by a single implantable device 120 or multiple devices.

[0030] The wearable appliance 101 may carry a power source 109. For illustrative purposes, the wearable appliance 101 is shown in FIG. 3B as including an oral appliance 123, e.g., a mouthpiece, which carries the power source 109. As noted above, the wearable appliance 101 may have other suitable configurations (e.g., a collar, a chin strap, a pillow, a mattress overlay) in other embodiments. The power source 109 provides power to the signal generator 110, which generates and directs signals (e.g., therapeutic signals) to one or more electrodes 131 carried by a signal delivery device 130. The signal delivery device 130 may be implanted at or near the patient's hypoglossal nerve (HGN) using a minimally invasive method, e.g., using a percutaneous needle. The power source 109 provides power to the signal generator 110 via a wireless power transmission link 114, e.g., a mid-field RF transmission link.

[0031] The signal generator 110 is typically controlled by the wearable device 101, which may be controlled by a programmer 160 and / or any other suitable device via a wireless programmer link 161. Thus, the patient P and / or a physician may use the programmer 160 to direct the signal generator 110 (through the wearable device 101) to send specific signals to specific electrodes at specific times and / or in specific sequences. The programmer link 161 may be a bidirectional link, such that the programmer 160 (in addition to providing instructions to the wearable device 101 and / or signal generator 110) can receive data regarding therapy, the status of system components, and / or other suitable metrics. The data may be collected by one or more sensors 119 carried by the wearable device 101 (as shown generally in FIG. 3B ) and / or the implantable device 120. Additionally, programmer 160 may communicate with cloud 162 and / or other computer services to upload data received from patient P and / or download information to wearable device 101 and / or implantable device 120. The downloaded data may include instructions and / or other data regarding appropriate treatment (e.g., from other similarly situated patients), updates for software running on circuitry carried by wearable device 101 and / or implantable device 120, and / or other useful information. In other embodiments, implantable device 120 and / or wearable device 101 include state machine components that are not updatable. Representative data received from the patient may include, among others, respiratory rate, sleep state, wakefulness state, heart rate, audio signals (audible snoring, hypopnea events, and / or apnea events), body temperature, head orientation / position, saturated blood oxygen level, airflow level, thyroid activity, tracheal activity, and / or tongue activity, photoplethysmography (PPG) data. The data received from the patient may be generated by a device 119 carried by the wearable device 101 and / or implantable device 120.In an exemplary embodiment, the wearable device 101 performs executive functions, such as synchronizing information received from the programmer 160 and / or sensors 119 to initiate, adjust, and / or terminate therapy delivered to the patient. Accordingly, circuitry carried by the wearable device may include a controller programmed with instructions for initiating, modifying, and / or terminating therapy delivered to the implantable device based on information received from the sensors. The received data may correspond to a measure of a metric used to rate the patient's respiratory performance, sleep state, wakefulness, and / or other suitable metric, such as the Apnea Hypopnea Index (AHI).

[0032] In any of the above-described embodiments, wearable device 101 transmits power to implantable device 120 via one or more power transmission links 112 and receives power (e.g., in an intermittent manner) from charger 121. Charger 121, as described above and with reference to FIG. 3A, may therefore employ a conventional inductive coupling arrangement (e.g., Qi standard charging) and / or a conventional wired connection scheme.

[0033] For comfortable wear, the wearable appliance 101 (whether an oral appliance 123 or other type of wearable) may be custom-fit to the patient or may be made available in various sizes and / or partially configurable to suit individual patients. The oral appliance 123 is optimal when the associated signal delivery appliance 130 is positioned at or near a target nerve population (e.g., the HGN) within the oral cavity. Whether the wearable appliance has a mouthpiece form factor or another suitable form factor, power can be provided to the implantable appliance 120 even when the wearable appliance is used to target nerve populations other than and / or in addition to the HGN, such as branches of the vagus nerve and / or cervical fasciculus. In yet another embodiment, the power source 109 can be attached to the patient's skin with an adhesive, although it is anticipated that avoiding adhesives will be more desirable / effective for the patient.

[0034] With reference to the particular embodiment shown in FIG. 3B , the oral appliance 123 may include both an upper mouthpiece portion 111 and a lower mouthpiece portion 112. The two mouthpiece portions 111, 112 may be coupled together by a connector 113. The connector 113 may provide a wired communication link between the two mouthpiece portions and / or may mechanically position (and / or maintain or stabilize) the lower mouthpiece portion 112 relative to the upper mouthpiece portion 111. Using this approach, for example, the patient's lower jaw or mandible M may be advanced relative to the patient's upper jaw as indicated by the bony structure BS in FIG. 3B . For example, embodiments of the present technology use physical elements of the wearable appliance 101 in addition to electrical stimulation powered by the wearable appliance to avoid or at least reduce jaw relaxation (a state in which the patient's mouth hangs open). For example, a wearable appliance with a collar and / or chin strap may mechanically stabilize the patient's jaw in a target position.

[0035] The power source 109 may include one or more charge storage devices 116 (e.g., one or more batteries) that receive power from the charger 121 and store the power for transfer to the implantable device 120. Accordingly, the power source 109 may include circuitry 115 (e.g., a first circuitry) that receives power from the charge storage devices 116, conditions the power, and transfers the power to the transmitting antenna 118. The transmitting antenna 118 transfers power to the implantable device 120 via the wireless power transmission link 114 and an electrode receiver antenna 133 carried by the signal transmission device 130.

[0036] Oral appliance 123 may further include a data transmitting / receiving antenna 117 for receiving data from and / or transmitting data to programmer 160. The data transmitted to programmer 160 may include sensor data obtained from one or more sensors 119. Thus, oral appliance 123 may carry the functional elements / components necessary to direct power to signal emitting device 130 and communicate with programmer 160 to provide effective treatment for the patient. Further details regarding signal emitting device 130 and signal generator 110 are described below with reference to Figures 4-8B.

[0037] FIG. 4 is a partial schematic side view of a signal transmission device 130 having components configured in accordance with an exemplary embodiment of the present technology. Representative dimensions are shown in FIG. 4 to provide a sense of scale, but the present technology is not limited by these dimensions unless expressly specified. The signal transmission device 130 has a lead body 134 that can be generally flexible and can carry one or more electrodes 131, which in some embodiments can be generally rigid and in other embodiments can be flexible. Flexible electrodes increase the flexibility of the overall lead body to accommodate tortuous anatomical structures / insertion paths near the target nerve. For illustrative purposes, the lead body 134 is shown in FIG. 4 as carrying four electrodes 131, but in other embodiments, the lead body 134 can carry any other suitable number of electrodes, for example, two electrodes 131. The electrodes 131 can be arranged in an array, for example, a one-dimensional linear array. The electrodes 131 may include conventional ring-shaped or cylindrical electrodes made of a suitable biocompatible material, such as platinum / iridium, stainless steel, MP35N, and / or other suitable conductive implant materials. The electrodes 131 may each be coupled to an individual conductor 140, such as a thin wire filament, that extends through the lead body 134. Each electrode 131 may have a length of approximately 1.5 mm, as shown in FIG. 4, or may have another suitable length in other embodiments. The electrodes 131 are typically connected to each other in pairs (at least one pair) to form a closed circuit. The housing 135 and / or portions of the housing 135 may serve as electrodes, such as ground or return electrodes.

[0038] The lead body 134 is connected to and carried by a housing 135, which carries the signal generator 110 and circuitry for receiving power. For example, the entire housing 135 may include an antenna housing or housing portion 135a and a circuit housing or circuit housing portion 135b. The antenna housing 135a may be flexible and may carry a receiver antenna 133 (or other suitable power receiving device) that receives power from the wearable device 101 (FIGS. 3A and 3B) via the wireless power transmission link 114. The circuit housing 135b may be in the form of a generally circular metal “can” made of titanium and / or another suitable material. The signal generator 110 may include a charge pump and / or DC-DC converter 139 and / or circuitry 138 (e.g., a second circuitry portion) coupled to the receiver antenna 133. The circuitry 138 may include an ASIC that may contain corresponding machine-readable instructions. The instructions may be updated wirelessly using the electrode receiver antenna 133 for data transmission in addition to power transmission. For example, data may be transmitted using pulse-width modulation (PWM) and / or other suitable techniques. Data may also be transmitted in the reverse direction using, for example, backscatter and / or other suitable techniques. For example, the implantable device 120 may transmit a receipt indicating that power has been received and how much power. This information may be used to self-adjust (up or down) the output of the signal generator 110, e.g., the transmitted signal and phase. Thus, the circuitry 138 may include a processor and memory, including pre-programmed and updatable instructions (e.g., in the form of an ASIC), for delivering the therapy signal to the patient. For example, the system may include a boot loader embedded firmware. Furthermore, the overall system can identify multiple implantable devices that may be powered by a single wearable device 101 using RFID-based power transmission authentication methods.When RFID and / or other technologies are used, security measures may be implemented to prevent foreign object or unintended stimulation, which, in at least some embodiments, may be implemented by appropriate hardware / software implemented in implantable device 120.

[0039] The entire housing portion 135 may further include a generally rigid base 136 and one or more anchors 137. The anchors 137 securely position the implantable device 120 relative to the patient's tissue. In an exemplary embodiment, the anchors 137 include one or more teeth that extend outward and into the patient's tissue when the implantable device 120 is injected or otherwise implanted within the patient's body. In other embodiments, the implantable device 120 may include other suitable anchors, and / or anchoring may occur at the distal and / or intermediate sections of the signal sending device 130. Other suitable anchors include, but are not limited to, (a) a bow spring that extends the longitudinal length of the electrode array and bends to create a locking frictional force when the introducer sheath is retracted; (b) a thin wire mounted on a spring-loaded hinge that extends the longitudinal length of the electrode array and bends to create a locking frictional force when the introducer sheath is retracted; (c) a cam that expands in diameter when rotated to create a frictional locking action when the corresponding push rod is turned by the implanter; and / or (d) a torsion spring that expands in diameter when rotated to create a frictional locking action when the corresponding push rod is turned by the implanter.

[0040] To implant the implantable device 120, a physician positions the implantable device 120 at the desired target location using a typical set of percutaneous implant tools, such as an introducer, needle, cannula, and stylet. In certain embodiments, the implantable device 120 is percutaneously implanted with a 3-4 French needle. As the implantable device 120 is advanced through the cannula, the anchors 137 can deploy outward and secure the implantable device 120 in place. When the stylet is removed from the implantable device 120, for example, by axially withdrawing the stylet from a hole in the base 136 and / or other portions of the housing portion 135, the implantable device 120 is ready to receive power and deliver a therapeutic signal to the target nerve.

[0041] In operation, the receiver antenna 133 receives power wirelessly from a power source 109 carried by an associated wearable device 101 (described in more detail below with reference to FIGS. 3A and 3B and 5A-6). In at least some embodiments, the power received at the receiver antenna 133 is at a radio frequency in the midfield range, e.g., in the range of about 300 MHz to about 6 GHz, e.g., in the range of about 600 MHz to about 2.45 GHz, or in the range of about 900 MHz to about 1.2 GHz. At this frequency, the usable range of the wireless power transmission link 114 is about 10 cm, well beyond the distance sufficient to span the distance between the implantable device 120 and the wearable device 101. In this range, the power transmission process is not expected to result in tissue heating, thus providing an advantage over other power transmission technologies, such as inductive power transmission technologies. However, in embodiments where the potential heating caused by inductive power transmission methods is adequately controlled, dielectric techniques can be used in place of the mid-field power transmission techniques described herein.

[0042] AC power received at receiver antenna 133 is rectified to DC and then transmitted to DC-DC converter, charge pump, and / or transformer 139 and converted into pulses ranging from about 10 Hz to about 300 Hz. In other embodiments, the pulses may be transmitted at higher frequencies (e.g., 10 kHz or greater) and / or in bursts. The signal amplitude may be from about 1 mV to about 5 V (in certain embodiments, 1 V to 2 V) for a voltage-controlled system or from about 1 mA to about 6 mA for a current-controlled system. Circuitry 138 controls these signal transmission parameters and transmits the resulting electrical signal to electrode 131 via a wire filament or other conductor 140 within lead body 134. Thus, circuitry forms (or forms at least a portion of) signal generator 110 in that it receives power transmitted wirelessly to implantable device 120 and generates a signal that is ultimately transmitted to the patient. The electric field resulting from the current applied by electrode 131 produces the desired effect (e.g., excitation and / or inhibition) at the target nerve. In at least some embodiments, implantable device 120 need not include any on-board power storage elements (e.g., power capacitors and / or batteries) to reduce system volume or need not include any power storage elements with a storage capacity greater than 0.5 seconds. In other embodiments, implantable device 120 may include one or more small charge storage devices (e.g., capacitors) that are compatible with the overall compact shape of implantable device 120 and have a total charge storage capacity of 1 second or less, 30 seconds or less, 1 minute or less, 2 minutes or less, or 5 minutes or less, depending on the embodiment.

[0043] In at least some embodiments, the electrical signal delivered to the patient may be delivered by a bipole formed by two of the electrodes 131. In other embodiments, the signal may be a unipolar signal, with the housing 135 (e.g., circuit housing portion 135b) forming the ground or return electrode. Typically, the waveform comprises a biphasic, charge-balanced waveform, as described in more detail below with reference to Figures 8A and 8B.

[0044] 5A-6 illustrate a wearable device 101 configured to deliver power to an implantable device 120 in accordance with an exemplary embodiment of the present invention. Referring initially to FIG. 5A, the exemplary wearable device 101 includes an oral appliance 123 having an upper mouthpiece portion 111 and a lower mouthpiece portion 112. The lower mouthpiece portion 112 has one or more transmitting antennas 118 that direct power to the implantable device 120, as described above with reference to FIG. 4. In the exemplary embodiment, the patient wears two implantable devices 120, implanted bilaterally, i.e., at each of the patient's two hypoglossal nerves, with one implantable device positioned on the right side of the patient's mouth and the other implantable device positioned on the left side. Accordingly, the oral appliance 123 may have two transmitting antennas 118, each positioned to direct power to each of the implantable devices 120, respectively. 5A, the lower mouthpiece portion 112 has two corresponding extensions 124, shown as left extension 124a and right extension 124b. Each extension 124 houses a respective one of the transmitting antennas 118, and each extension is positioned to position the transmitting antenna 118 near a corresponding implantable appliance 120 in a manner that remains comfortable for the patient when the patient wears the oral appliance 123.

[0045] The oral appliance 123 further includes one or more power sources 116 coupled to the circuitry 115, which directs power to the transmitting antenna 118. The power source 116 may include one or more batteries, capacitors, and / or other charge storage devices configured to store sufficient energy to power the signal transmission device for a suitable treatment period, which typically includes at least four hours in some embodiments and at least overnight in other embodiments. The circuitry 115 receives electrical current from the power source 116 and converts the current to suitable mid-field radio frequency waves. The electrical current is directed to the transmitting antenna 118. In the embodiment shown in FIG. 5A , the circuitry 115 and power source 116 are carried by the lower mouthpiece portion 112, and are positioned along the exterior of the lower mouthpiece portion 112 so as to face the patient's lower lip. In this configuration, the electrical elements are not expected to interfere with the patient's forward tongue movement. In another embodiment, as shown in FIG. 5B , for example, circuitry 115 and power source 116 may be carried by upper mouthpiece portion 111. In this embodiment, circuitry 115 and power source 116 are positioned along the inner surface of upper mouthpiece portion 111 so as to face toward the interior of the patient's oral cavity, rather than toward the patient's lips. Because the electrical elements are located on upper mouthpiece portion 111, they are not expected to interfere with the forward movement of the patient's tongue, even though they face toward the interior of the patient's oral cavity. Circuitry 115 directs electrical current to the antenna by one or more wires (not shown in FIG. 5A ) that pass correspondingly through connector 113 (shown in FIG. 3B ) coupled between upper mouthpiece portion 111 and lower mouthpiece portion 112.

[0046] 5C shows another exemplary embodiment in which wearable appliance 101 has circuitry 115 carried by upper mouthpiece portion 111 and power source 116 carried by lower mouthpiece portion 112. In this case, a communications link carried by connector 113 (FIG. 3B) carries current from power source 116 to circuitry 115, which in turn carries current from circuitry 115 to transmitting antenna 118 (not visible in FIG. 5C).

[0047] 6 is a partial schematic isometric view of a wearable appliance 601 configured in accordance with yet another embodiment of the present technology. The upper mouthpiece portion 111 has a roof portion 622 extending laterally from one side of the upper mouthpiece portion 111 to the other side thereof for being positioned upward against the roof of the patient's mouth. Accordingly, several of the components of the wearable appliance 101 may be carried by the roof portion 622. Such components include the circuitry 115, the power source 116, the data transmit / receive antenna 117 (described above with reference to FIG. 3B ), the charging coil 621 (which recharges the power source 116 with the charger 121 shown in FIGS. 3A and 3B ), and one or more sensors 119 (also described above with reference to FIGS. 3A and 3B ). Thus, the roof portion 622 may provide an additional volume for housing and carrying the above-described components of the wearable appliance 101. Sensors 119 may include, but are not limited to, temperature sensors, e.g., thermistors and / or thermocouples, acoustic sensors, vibration sensors, pressure sensors, force sensors, strain gauges, magnetometers, accelerometers, gyroscopes, impedance sensors, EMG sensors, gas and / or chemical sensors, oxygen saturation sensors, photoplethysmography sensors, flow sensors (oral or nasal manometry), and / or other sensors capable of detecting a patient's state or characteristic (e.g., sleep state, wakefulness state). In some exemplary embodiments, patient respiratory parameters may be used to trigger stimulation based on the patient's respiratory cycle and information that may indicate that an apnea event is occurring or imminent. In certain embodiments, the overall system includes a pulse oximeter, a photoplethysmography sensor, and at least one patient positioning sensor to provide appropriate patient feedback on which system action can be based.

[0048] 5A-6 may be located along the outer surface of the mouthpiece portion, or in other embodiments, the components may face inward rather than outward from the mouthpiece portion. As noted above, an advantage of components located on the outer surface of the mouthpiece is that they do not impinge on the space occupied by the tongue when it is thrust forward during stimulation. In at least some embodiments, the battery may be positioned so that it can be easily removed and replaced.

[0049] 7 is a schematic diagram of an apparatus for controlling electrical signals applied to a patient in accordance with an exemplary embodiment of the present technology. Generally, control circuitry 115 provides electrical current to one or more transmitting antennas 118, which direct power to corresponding electrode receiver antennas 133 via corresponding wireless power transmission links 114.

[0050] For illustrative purposes, FIG. 7 shows two example control configurations on a single appliance, one for the left side of a patient's mouth and one for the right side. This is one possible configuration; in other embodiments, the same configuration is used for both the left and right sides. As shown in FIG. 7, a first receiver antenna 133a can provide a signal to each of four corresponding electrodes 131. Two second receiver antennas 133b can each provide power to two electrodes 131. The implementation configuration may be selected based on the utility associated with controlling individual electrodes by the corresponding receiver antennas. For example, the first receiver antenna 133a can simultaneously send the same signal to multiple electrodes 131 (and / or pairs of electrodes 131) connected to it. Meanwhile, the second receiver antennas 133b can each independently send signals to their associated corresponding electrodes. This allows the second receiver antennas 133b to sequence the signals applied to the corresponding electrodes 131. In some embodiments, this configuration advantageously allows a physician to direct one signal to one portion of the hypoglossal nerve at one time and the same or a different signal to another portion of the hypoglossal nerve or another nerve at another time. As expected, the ability to control both the spatial and temporal aspects of the signals delivered to one or more target nerves can improve the effectiveness of the device in alleviating obstructive sleep apnea (OSA) in a patient. For example, signals can be delivered to different portions of the hypoglossal nerve and / or other nerves, including the cervical fasciculus (e.g., to facilitate caudal movement of the pharynx) and / or the vagus nerve, whose branches activate many muscles of the upper airway, including the pharyngeal and palatine motor muscles.

[0051] More generally, multiple implantable electrodes 131 may be wirelessly activated by a remotely positioned wearable device in a phased manner (e.g., with timing offsets in the millisecond range) to sequence the contractions of corresponding muscles, thereby addressing the patient's sleep disorder. Additionally, the system has the versatility to vary the target neurons to which the signal is directed, combined with the reliability and robustness offered by the implanted signal delivery device.

[0052] In at least some embodiments, the control circuitry 115 controls both transmitting antennas 118, thus allowing overall control of the signals delivered to the patient. In other embodiments, the authority to control one or more antennas 118 and / or corresponding electrodes 131 may be decentralized. For example, one element of the control circuitry may control one transmitting antenna 118, and another component may control the other transmitting antenna 118. Control authority may be further decentralized to different receiver antennas 133, as shown in FIG. 7. In any of these embodiments, when control is decentralized below the high-level control circuitry 115, the system includes means for enabling communication between the individual controller elements to keep all control components synchronized.

[0053] 4. Typical waveforms The signal generator and delivery device described above can generate and deliver any of a variety of suitable electrical stimulation waveforms to condition a patient's nerve and / or muscle activity. Representative embodiments are shown in FIGS. 8A and 8B, which include a series of biphasic stimulation pulses forming a stimulation wave cycle having a period as specified in FIGS. 8A and 8B. Waveform parameters may include an active cycle and a rest cycle. Each period P includes one or more pulses. The waveform shown in FIG. 8A includes an anodic pulse, followed by an interphase delay, followed by a cathodic pulse, followed by an interpulse delay. Thus, the period P, or cycle in general, includes the following parameters: anodic pulse width (PW1), anodic amplitude (e.g., voltage or current amplitude VA), interphase delay / dead time, cathodic pulse width (PW2), cathodic amplitude (e.g., voltage or current amplitude VC), interpulse delay / dead time, and peak-to-peak amplitude (PP). The parameters may further include an indication of the identity of the electrode to which the signal is directed. In some embodiments, the anodic pulse width (PW1) is 30 μs to 300 μs. In some embodiments, the anodic amplitude (VA) and cathodic amplitude (VC) are in the range of 1 mV to 5 V, or 1 mA to 6 mA. In representative embodiments, the interphase delay may be 10 μs to 100 μs. In some representative embodiments, the cathodic pulse width (PW1) is 30 μs to 300 μs. In representative embodiments, the anodic and cathodic phases are charge-balanced, although the phases need not be symmetrical. In some representative embodiments, the interpulse delay may be 10 μs to 100 μs. In some representative embodiments, the peak-to-peak amplitude may be about 2 mA to 12 mA. Representative frequencies range from about 10 Hz to about 300 Hz in some embodiments, and up to 100 kHz (e.g., 10 kHz) in other embodiments. These pulses can be delivered continuously or in bursts.

[0054] FIG. 8B shows an exemplary waveform including an active portion and a rest portion. The active portion includes one or more periods having the characteristics described above with reference to FIG. 8A. The rest portion is free of stimulation pulses. According to some exemplary embodiments, the ratio of active to rest portions may be between 1:1 and 1:9. As an exemplary example, if the ratio is 1:9 and there are 300 active periods, there may be 2700 rest portions.

[0055] In a representative embodiment, stimulation voltages may be provided independently to each contact or electrode. For a positive pulse, the positive contact may be pulled to the drive voltage and the negative contact may be pulled to ground. For a negative pulse, the negative contact may be pulled to the drive voltage and the positive contact may be pulled to ground. For dead and idle times, both contacts are driven to ground. For rest times, both contacts are in a high impedance state. To prevent DC current through the contacts, each half-bridge may be coupled to the contacts by a capacitor, e.g., a 100 μF capacitor. Additionally, resistors may be placed in series with each capacitor to limit current in the event of a contact short. The pulses of a treatment waveform cycle may or may not be symmetrical, but are generally shaped to result in a net zero charge across the contacts, e.g., to provide charge balance.

[0056] From the foregoing, it will be appreciated that, while specific embodiments of the present technology have been described herein for illustrative purposes, various modifications can be made without departing from the present technology. For example, the power source and associated wearable can have configurations other than an intraoral mouthpiece that also wirelessly deliver power to one or more implanted electrodes. Exemplary configurations include external skin-attached devices and appliances worn around the patient's neck, which may be suitable for targeting nerves other than the cervical nerve trap, vagus nerve, and / or HGN. Other exemplary targets for stimulation include glossopalatine stimulation, cranial nerve stimulation, direct glossopalatine muscle stimulation, nasopharyngeal stimulation, and / or glossopharyngeal nerve stimulation. The anchors used to secure the signal transmission device in place can have configurations other than deployable teeth, including S-curve elements, spirals, and / or porous structures that promote tissue ingrowth. Signal transmission devices including multiple housings forming an entire housing have been described above. In other embodiments, the multiple housings may be part of a single, integrated housing. The functions performed by the overall system may be divided among the system components (e.g., programmer, wearable device, and implantable device) in ways other than those explicitly illustrated and described herein.

[0057] Certain aspects of the technology described in connection with a particular embodiment may be combined or omitted by other embodiments. For example, a signal transmission device having any of a variety of suitable configurations may be used with any one signal generator, and a signal generator having any of a variety of suitable configurations may be used with any one signal transmission device. Furthermore, although advantages associated with a particular embodiment of the disclosed technology have been described in connection with this embodiment, other embodiments within the scope of the technology may also enjoy such advantages, although not all embodiments necessarily do. Thus, the present disclosure and related technology may include other embodiments not explicitly shown or described herein.

[0058] As used herein, the phrase "and / or," such as "A" and / or "B," means A alone, B alone, and both A and B. To the extent that any material incorporated by reference conflicts with this disclosure, this disclosure controls. As used herein, the terms "about," "approximately," and similar approximation terms mean values ​​within 10% of the specified value.

[0059] The following embodiments provide additional representative features of the present technology.

[0060] Implementation [Embodiment 1] 1. A patient care system comprising: The wearable device includes: a power storage device; a transmitting antenna coupled to the power storage device and configured to emit RF signals in a frequency range from 300 MHz to 6 GHz; a first control circuit coupled between the power storage device and the power transmitting antenna; an implantable device, the implantable device comprising: An electrode; a housing carrying the electrodes; an anchor carried by the housing and positioned to secure the implantable device to tissue within the patient's oral cavity; an electrode receiver antenna configured to receive RF signals in the frequency range of 300 MHz to 6 GHz; a signal generator coupled to the electrode receiver antenna and to the electrode to direct a signal to the electrode at a frequency ranging from 10 Hz to 300 Hz; and second circuitry coupled between the signal generator and the electrode for controlling delivery of the signal to the electrode. [Embodiment 2] The implantable device is a needle-delivered device, the electrode is positioned to be implanted near the patient's hypoglossal nerve and / or cervical nerve trap, and the system further comprises: at least one sensor carried by the wearable or implantable device, the at least one sensor configured to detect a characteristic of the patient's respiratory performance; The patient treatment system of embodiment 1 includes a controller carried by the wearable device and programmed with instructions that, when executed, initiate, modify, and / or stop the delivery of the signal to the electrode based in part on information received from the at least one sensor. [Embodiment 3] 3. The patient treatment system of claim 2, wherein the at least one sensor includes a pulse oximeter, a photoplethysmography sensor, and a patient positioning sensor. [Embodiment 4] 4. A patient care system according to any one of the preceding embodiments, wherein the implantable device does not include a charge storage element. [Embodiment 5] A patient treatment system as described in any one of embodiments 1 to 4, wherein the electrode is a first electrode, the implantable device has a second electrode, and at least one of the first circuit unit or the second circuit unit includes instructions that, when executed, direct signals to the first and second electrodes in an ordered sequence, the first electrode delivering a first signal to the patient at a first time point, and the second electrode delivering a second signal to the patient at a second time point. [Embodiment 6] 5. The patient treatment system of any one of embodiments 1 to 4, wherein the wearable appliance comprises an oral appliance configured to be positioned within the patient's oral cavity. [Embodiment 7] 7. The patient treatment system of embodiment 6, wherein at least a first portion of the oral appliance is configured to conform to at least a second portion of the patient's oral cavity. [Embodiment 8] 7. The patient treatment system of embodiment 6, wherein the oral appliance comprises an upper mouthpiece portion, a lower mouthpiece portion, and a connector connecting the upper and lower mouthpiece portions. [Embodiment Item 9] 9. The patient treatment system of embodiment 8, wherein the lower mouthpiece portion is movable relative to the upper mouthpiece portion to advance the patient's mandible. [Embodiment 10] 9. The patient treatment system of claim 8, wherein the lower mouthpiece portion carries the transmitting antenna, the charge storage device, and the first circuitry. [Embodiment 11] 9. The patient treatment system of claim 8, wherein the lower mouthpiece portion carries the transmitting antenna and the upper mouthpiece portion carries the charge storage device and the first circuit portion. [Embodiment 12] 12. The patient treatment system of claim 11, wherein the upper mouthpiece portion includes a roof portion carrying the charge storage device or the first circuit portion. [Embodiment 13] The patient treatment system of embodiment 8, wherein the lower mouthpiece portion carries the power storage device, the upper mouthpiece portion carries the first circuit portion, and the connector has a communication link for transmitting power from a power source to the circuit portion. [Embodiment 14] 9. The patient treatment system of embodiment 8, wherein at least a portion of the lower mouthpiece portion is shaped to conform to a lower region of the patient's mouth. [Embodiment 15] 9. The patient treatment system of embodiment 8, wherein at least a portion of the upper mouthpiece portion is shaped to conform to an upper region of the patient's oral cavity. [Embodiment 16] A patient treatment system according to any one of embodiments 1 to 15, wherein (i) the implantable device is a first implantable device positioned on a first side of the patient's oral cavity, and (ii) the electrode is a first electrode, and the system further includes a second implantable device positioned on a second side of the patient's oral cavity opposite the first implantable device, the second implantable device having a second electrode. [Embodiment 17] The patient treatment system of any one of embodiments 1 to 5, wherein the wearable device comprises at least one of a neck collar, a chin strap, a pillow, and / or a mattress overlay. [Embodiment 18] At least one of the first circuit portion or the second circuit portion includes instructions that, when executed, cause the electrodes to deliver a signal to the patient, the signal comprising: Pulse width of 30μs~300μs, Anode amplitude of 1mA to 6mA or 1mV to 5V, and 18. The patient treatment system of any one of embodiments 1-17, comprising at least one of a cathodic amplitude of 1 mA to 6 mA or 1 mV to 5 V. [Embodiment 19] The patient treatment system of embodiment 1, wherein the wearable device further comprises at least one sensor positioned to detect at least one physiological parameter of the patient, the at least one physiological parameter comprising at least one of respiratory rate, heart rate, audio signals, body temperature, head position, saturated blood oxygen level, airflow level, laryngeal movement of the patient, and / or tongue movement of the patient. [Embodiment 20] 1. A sleep apnea treatment system, comprising: an oral appliance configured to fit within the patient's oral cavity, said oral appliance comprising: a lower mouthpiece portion carrying a transmitting antenna configured to emit an RF signal at a first frequency; and an upper mouthpiece portion located opposite the lower mouthpiece portion, the upper mouthpiece portion comprising: a power storage device operably coupled to the transmitting antenna; and carrying a first control circuit portion operably coupled to the power storage device and the transmitting antenna; a connector for connecting the lower mouthpiece portion and the upper mouthpiece portion, an implantable device, the implantable device comprising: An electrode; an electrode receiver antenna configured to receive the RF signal emitted by the transmitting antenna; a signal generator coupled to the electrode receiver antenna and the electrode and capable of directing a stimulation signal to the electrode at a second frequency; and a second circuit coupled between the signal generator and the electrode for controlling delivery of the stimulation signal to the electrode; [Embodiment 21] 21. The sleep apnea treatment system of embodiment 20, wherein the implantable device does not include a charge storage element. [Embodiment 22] The sleep apnea treatment system of embodiment 20 or 21, wherein the electrode is a first electrode, the implantable device has a second electrode, and at least one of the first circuit unit or the second circuit unit includes instructions that, when executed, direct a signal to the first and second electrodes in an ordered sequence, the first electrode delivering a signal to the patient at a first time point, and the second electrode delivering a signal to the patient at a second time point. [Embodiment 23] 1. A method of directing an electrical signal to an individual, comprising: programming the wearable device to transmit a first electrical signal via a transmitting antenna of the wearable device positioned in wireless communication with a receiver antenna of the implantable device, at least a portion of the first electrical signal having a first frequency in a first frequency range of about 300 MHz to about 6 GHz; programming a pulse generator of said implantable device; receiving the first electrical signal via the electrode receiver antenna; and a step of transmitting a second electrical signal via at least one electrode of the implantable device positioned in electrical communication with a target nerve of the individual, at least a portion of the second electrical signal having a second frequency in a second frequency range up to 100 kHz. [Embodiment 24] 24. The method of embodiment 23, wherein the first frequency range is from about 900 MHz to about 1.2 GHz. [Embodiment 25] 25. The method of embodiment 23 or 24, wherein the second frequency range is from about 10 Hz to about 300 Hz. [Embodiment 26] 26. The method of any one of embodiments 23-25, wherein said portion of said second electrical signal further has an anodic amplitude in an anodic amplitude range of 1 mV to 5 V, or 1 mA to 6 mA. [Embodiment 27] 27. The method of any one of embodiments 23 to 26, wherein said portion of said second electrical signal further has an inter-phase delay in the inter-phase delay range of 10 μs to 100 μs. [Embodiment 28] 28. The method of any one of embodiments 23 to 27, wherein the portion of the second electrical signal further has an interpulse delay in the interpulse delay range of 10 μs to 100 μs. [Embodiment 29] 29. The method of any one of embodiments 23 to 28, wherein said portion of said second electrical signal further has a peak-to-peak amplitude within a peak-to-peak amplitude range of 2 mA to 12 mA. [Embodiment 30] 30. The method of any one of embodiments 23 to 29, wherein the individual suffers from sleep apnea. [Embodiment 31] 31. The method of any one of embodiments 23-30, wherein said programming said pulse generator comprises programming said pulse generator to deliver said second electrical signal for a treatment period. [Embodiment 32] The method of embodiment 31, wherein said treatment period lasts for at least 4 hours. [Embodiment 33] 32. The method of embodiment 31, wherein said treatment period comprises at least one active portion and at least one rest portion. [Embodiment 34] 1. A method of treating a patient, comprising: percutaneously implanting an implantable device near the patient's medial branch of the hypoglossal nerve such that an electrode carried by the implantable device is positioned in electrical communication with the medial branch of the patient's hypoglossal nerve; transmitting a first signal from a transmitting antenna of the wearable device to a receiver antenna of the implantable device; converting the first signal to a second signal by a signal generator of the implantable device; applying the second signal via the electrode to the medial branch of the patient's hypoglossal nerve. [Embodiment 35] 35. The method of embodiment 34, wherein said step of transmitting said first signal includes transmitting said first signal in a frequency range from about 300 MHz to about 6 GHz. [Embodiment 36] 36. The method of embodiment 34 or 35, wherein said step of transmitting said second signal comprises transmitting said second signal in a frequency range up to 100 kHz. [Embodiment 37] 37. The method of any one of embodiments 34 to 36, wherein said step of transmitting said second signal includes the step of transmitting said second signal in a frequency range from about 10 Hz to about 300 Hz. [Embodiment 38] The electrode is a first electrode, and the step of applying the second signal includes: applying a first portion of the second signal via the first electrode at a first time; applying a second portion of the second signal at a second time via the second electrode. [Embodiment 39] The implantable device is a first implantable device, the electrode is a first electrode, and the method comprises: The method of any one of embodiments 34-38, further comprising percutaneously implanting a second implantable device such that a second electrode carried by the second implantable device is positioned in electrical communication with at least a portion of the patient's hypoglossal nerve, cervical fasciculus, vagus nerve, glossopharyngeal nerve, palatoglossus, or nasopharyngeal complex. [Embodiment 40] implanting the first implantable device includes implanting the first implantable device in a first side of the patient's oral cavity; 40. The method of embodiment 39, wherein the step of implanting the second implantable device comprises the step of implanting the second implantable device on a second side of the patient's oral cavity.

Claims

1. 1. A system for treating sleep apnea in a patient, comprising: A wearable device, comprising: A power storage device; a transmitting antenna coupled to the power storage device and configured to emit a power signal; a first control circuit coupled between the power storage device and the power transmitting antenna; and a percutaneously implantable device, the implantable device comprising: An electrode; a housing carrying the electrodes; an electrode receiver antenna configured to receive the power signal; one or more charge storage devices having a total charge storage capacity of 5 minutes or less; a signal generator operatively coupled to the electrode receiver antenna to receive the power signal from the electrode receiver antenna and operatively coupled to the electrode to direct a signal to the electrode at a frequency in the range of 10 Hz to 300 Hz; and second control circuitry coupled between the signal generator and the electrode to control delivery of the signal to the electrode.

2. The implantable device is a needle-delivered device, the electrode is configured to be implanted near a hypoglossal nerve and / or a cervical nerve trap of a patient, and the system further comprises: at least one sensor carried by the wearable or implantable device, the at least one sensor configured to detect a characteristic of a patient's respiratory performance; The system of claim 1 , further comprising a controller carried by the wearable apparatus and programmed with instructions that, when executed, initiate, modify, and / or stop the delivery of the signal to the electrodes based in part on information received from the at least one sensor.

3. The system of claim 2 , wherein the at least one sensor includes a pulse oximeter, a photoplethysmography sensor, and a patient positioning sensor.

4. The system of claim 1 , wherein the implantable device does not include a battery and / or power storage device.

5. 2. The system of claim 1, wherein the electrode is a first electrode, the implantable device further comprising a second electrode, and at least one of the first control circuitry or the second control circuitry includes instructions that, when executed, direct a signal to the first and second electrodes in an ordered manner, the first electrode delivering a first signal to the patient at a first time and the second electrode delivering a second signal to the patient at a second time.

6. The system of claim 1 , wherein the wearable appliance comprises an oral appliance configured to be positioned within the patient's oral cavity.

7. the implantable device being a first implantable device configured to be positioned on a first side of the patient's oral cavity; the electrode is a first electrode, 10. The system of claim 1, further comprising a second implantable device positioned on a second side of the patient's oral cavity opposite the first implantable device, the second implantable device having a second electrode.

8. The system of claim 1 , wherein the wearable appliance comprises at least one of a neck collar, a chin strap, a pillow, and / or a mattress overlay.

9. At least one of the first control circuitry or the second control circuitry includes instructions that, when executed, cause the electrodes to deliver a signal to the patient, the signal comprising: Pulse width of 30 μs to 300 μs, An anode amplitude of 1 mA to 6 mA or 1 mV to 5 V; and 10. The system of claim 1, comprising at least one of a cathode amplitude of 1 mA to 6 mA or 1 mV to 5V.

10. 2. The system of claim 1, wherein the wearable appliance further comprises at least one sensor configured to detect at least one physiological parameter of the patient, the at least one physiological parameter including at least one of a respiratory rate, a heart rate, an audio signal, a body temperature, a head position, a saturated blood oxygen level, an airflow level, a patient's laryngeal movement, and / or a patient's tongue movement.

11. The system of claim 1 , wherein the power signal is an RF signal having a frequency in the frequency range of 300 MHz to 6 GHz.

12. 1. A system for treating sleep apnea in a patient, comprising: A wearable device including a power transmission device configured to transmit a power signal; A signal sending device, The signal sending device comprises: An electrode; a housing carrying said electrodes and percutaneously implantable; a power receiving device configured to receive the power signal from the power transmitting device; a signal generator operably coupled to the power receiving device to receive power from the power receiving device and operably coupled to the electrodes to transmit signals to target tissue of a patient, the signal having a frequency in the range of 10 Hz to 300 Hz; one or more charge storage devices having a total charge storage capacity of five minutes or less.

13. The system of claim 12 , wherein the target tissue of the patient includes the patient's hypoglossal nerve.

14. The system of claim 12 , wherein the housing is adapted to be percutaneously injectable.

15. The system of claim 12 , wherein the housing is configured to be implanted in a patient by a percutaneous injection needle.

16. The system of claim 12 , wherein the power transmission device comprises an inductive coil.

17. The system of claim 12 , wherein the power transmitting device comprises an RF antenna.